Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. MedTech Solutions's annualized net income for the quarter that ended in Mar. 2026 was zł-1.40 Mil. MedTech Solutions's average shareholder tangible equity for the quarter that ended in Mar. 2026 was zł2.30 Mil. Therefore, MedTech Solutions's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -60.70%.
The historical rank and industry rank for MedTech Solutions's Return-on-Tangible-Equity or its related term are showing as below:
WAR:MDT'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -26193.75 Med: -499.07 Max: -250.27
Current: -250.27
During the past 12 years, MedTech Solutions's highest Return-on-Tangible-Equity was -250.27%. The lowest was -26,193.75%. And the median was -499.07%.
WAR:MDT's Return-on-Tangible-Equity is ranked worse than 98.58% of 1060
companies
in the Retail - Cyclical industry
Industry Median: 8.34
vs WAR:MDT: -250.27
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
MedTech Solutions Return-on-Tangible-Equity Related Terms
MedTech Solutions Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for MedTech Solutions's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:MDT vs AMZN, BABA, PDD: Return-on-Tangible-Equity Comparison
For the Internet Retail subindustry, MedTech Solutions's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedTech Solutions Return-on-Tangible-Equity vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, MedTech Solutions's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where MedTech Solutions's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -60.70% mean?
MedTech Solutions (WAR:MDT) has a Return-on-Tangible-Equity of -60.70% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MedTech Solutions and its competitors. According to the industry distribution chart, MedTech Solutions ranks #1045 out of 1060 companies in the Retail - Cyclical industry, placing it in the top 98.6%.
Is MedTech Solutions' Return-on-Tangible-Equity too high?
MedTech Solutions' current Return-on-Tangible-Equity is -60.70%. Based on the distribution chart, MedTech Solutions ranks #1045 out of 1060 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, MedTech Solutions has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MedTech Solutions' Return-on-Tangible-Equity compare to AMZN and BABA?
According to the Retail - Cyclical industry distribution chart, MedTech Solutions ranks #1045 out of 1060 companies for Return-on-Tangible-Equity. This places MedTech Solutions in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Retail - Cyclical company?
The median Return-on-Tangible-Equity among Retail - Cyclical companies is 8.34, based on 1,060 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on MedTech Solutions and its competitors. For the Retail - Cyclical industry, the median Return-on-Tangible-Equity is 8.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedTech Solutions's current Return-on-Tangible-Equity is -60.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedTech Solutions stock overvalued right now?
Based on GuruFocus' analysis, MedTech Solutions (WAR:MDT) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.04, compared to a current price of zł0.31 — trading 670% above its estimated fair value. The current Return-on-Tangible-Equity is -60.70%. MedTech Solutions' overall GF Score™ is 29/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For MedTech Solutions (WAR:MDT), the current Return-on-Tangible-Equity is -60.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedTech Solutions (WAR:MDT) Overvalued in 2026?
Based on GuruFocus' analysis, MedTech Solutions stock appears to be overvalued.
The current stock price of zł0.31 is trading 670% above its estimated GF Value™ of zł0.04.
GuruFocus considers MedTech Solutions to be Significantly Overvalued.
Key valuation signals for WAR:MDT:
Return-on-Tangible-Equity: -60.70%
GF Value™: zł0.04 vs. price of zł0.31 (670% above fair value)
No single metric tells the full story. See the WAR:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedTech Solutions SA formerly E-shopping Group SA main activity is based on conducting business through its own e-shops that operate in the dropshipping sales model.
29GF Score
Get the complete analysis for WAR:MDT
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MDT has been successfully added to your 
